In recent years,with the maturity of modern biological technology and the joint promotion of the international community,personalised medicine and its clinical research,which is dedicated to providing personalized medical services to patients,have made sig-nificant progress.In order to promote personalised medicine research and optimize its ecological environment,the European Commission established the International Consortium of Personalised Medicine(ICPerMed)to support the healthy development of personalised medi-cine in the form of project research.ICPerMed set the PERMIT project in 2020,which is dedicated to promoting the development of clini-cal research for personalised medicine.This study systematically introduces the overview,research goals,work content of PERMIT,and its related work suggestions for the development of clinical research for personalised medicine.At the same time,combined with the prog-ress and challenges of clinical research for personalised medicine in China,this study proposes several key work directions to promote healthy and efficient development of clinical research for personalised medicine,including policy formulation,regulatory framework and financial investment,so as to provide reference for related work.
维普
万方数据